Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease

Fonarow, G.C., Keech, A.C., Pedersen, T.R. et al. (8 more authors) (2017) Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease. JAMA Cardiology, 2 (10). pp. 1069-1078. ISSN 2380-6583

Abstract

Metadata

Authors/Creators:
  • Fonarow, G.C.
  • Keech, A.C.
  • Pedersen, T.R.
  • Giugliano, R.P.
  • Sever, P.S.
  • Lindgren, P.
  • van Hout, B.
  • Villa, G.
  • Qian, Y.
  • Somaratne, R.
  • Sabatine, M.S.
Copyright, Publisher and Additional Information: © 2017 American Medical Association. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published (online): 23 August 2017
  • Published: October 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 28 Sep 2017 12:08
Last Modified: 23 Aug 2018 00:38
Published Version: https://doi.org/10.1001/jamacardio.2017.2762
Status: Published
Publisher: American Medical Association
Refereed: Yes
Identification Number: https://doi.org/10.1001/jamacardio.2017.2762
Related URLs:

Share / Export

Statistics